Cargando…
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
The development of an effective and durable vaccine remains a central goal in the fight against malaria. Circumsporozoite protein (CSP) is the major surface protein of sporozoites and the target of the only licensed Plasmodium falciparum (Pf) malaria vaccine, RTS,S/AS01. However, vaccine efficacy is...
Autores principales: | Ludwig, Julia, Scally, Stephen W., Costa, Giulia, Hoffmann, Sandro, Murugan, Rajagopal, Lossin, Jana, Prieto, Katherine, Obraztsova, Anna, Lobeto, Nina, Franke-Fayard, Blandine, Janse, Chris J., Lebas, Celia, Collin, Nicolas, Binter, Spela, Kellam, Paul, Levashina, Elena A., Wardemann, Hedda, Julien, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080175/ https://www.ncbi.nlm.nih.gov/pubmed/37029167 http://dx.doi.org/10.1038/s41541-023-00653-7 |
Ejemplares similares
-
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023) -
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018) -
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
por: Mallory, Katherine L., et al.
Publicado: (2021) -
Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
por: Oludada, Opeyemi Ernest, et al.
Publicado: (2023) -
Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
por: Martin, Gregory M., et al.
Publicado: (2023)